Fibroblasts mediate induction of high mobility group box protein 1 in lung epithelial cancer cells by diffusible factors

International Journal of Molecular Medicine

Volumn 20, Issue 2, 2007, Pages 217-224

  Bartling, Babett ^a   Fuchs, Christine ^a   Silber, Rolf Edgar ^a   Simm, Andreas ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cancer; Epithelial cells; Fibroblasts; High mobility group box protein 1; Lung

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN;

ARTICLE; BIOSYNTHESIS; CARCINOMA; CELL CULTURE; CULTURE MEDIUM; EPITHELIUM CELL; FIBROBLAST; HUMAN; LUNG; LUNG TUMOR; METABOLISM; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA; SECRETION; TISSUE DISTRIBUTION;

CARCINOMA; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; FIBROBLASTS; HMGB1 PROTEIN; HUMANS; LUNG; LUNG NEOPLASMS; RESPIRATORY MUCOSA; TISSUE DISTRIBUTION;

EID: 35448983210     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.20.2.217     Document Type: Article

References (52)

1. Goodwin GH, Sanders C and Johns EW: A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem 38: 14-19, 1973.
2. Bustin M: Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 19: 5237-5246, 1999.
3. Lum HK and Lee KL: The human HMGB1 promoter is modulated by a silencer and an enhancer-containing intron. Biochim Biophys Acta 1520: 79-84, 2001.
4. Rauvala H and Pihlaskari R: Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons. J Biol Chem 262: 16625-16635, 1987.
5. Zhao Z, Chou DK, Nair SM, Tobet S and Jungalwala FB: Expression of sulfoglucuronyl (HNK-1) carbohydrate and its binding protein (SBP-1) in developing rat cerebellum. Brain Res Dev Brain Res 120: 165-180, 2000. (Pubitemid 30209909)
6. Calogero S, Grassi F, Aguzzi A, et al: The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet 22: 276-280, 1999.
7. Degryse B, Bonaldi T, Scaffidi P, et al: The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 152: 1197-1206, 2001.
8. Fiuza C, Bustin M, Talwar S, et al: Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101: 2652-2660, 2003.
9. Wang H, Yang H and Tracey KJ: Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 255: 320-331, 2004.
10. Nagatani G, Nomoto M, Takano H, et al: Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells. Cancer Res 61: 1592-1597, 2001.
11. Brezniceanu ML, Volp K, Bosser S, et al: HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. FASEB J 17: 1295-1297, 2003.
12. Wood LJ, Maher JF, Bunton TE and Resar LM: The oncogenic properties of the HMG-I gene family. Cancer Res 60: 4256-4261, 2000.
13. Volp K, Brezniceanu ML, Bosser S, et al: Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut 55: 234-242, 2006.
14. Gardella S, Andrei C, Ferrera D, et al: The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 3: 995-1001, 2002.
15. Bustin M and Neihart NK: Antibodies against chromosomal HMG proteins stain the cytoplasm of mammalian cells. Cell 16: 181-189, 1979.
16. Mosevitsky MI, Novitskaya VA, Iogannsen MG and Zabezhinsky MA: Tissue specificity of nucleo-cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions. Eur J Biochem 185: 303-310, 1989.
17. Fages C, Nolo R, Huttunen HJ, Eskelinen E and Rauvala H: Regulation of cell migration by amphoterin. J Cell Sci 113: 611-620, 2000.
18. Rouhiainen A, Imai S, Rauvala H and Parkkinen J: Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb Haemost 84: 1087-1094, 2000.
19. Charoonpatrapong K, Shah R, Robling AG, et al: HMGB1 expression and release by bone cells. J Cell Physiol 207: 480-490, 2006.
20. Sparatore B, Patrone M, Passalacqua M, et al: Extracellular processing of amphoterin generates a peptide active on erythroleukaemia cell differentiation. Biochem J 357: 569-574, 2001.
21. Ulloa L and Messmer D: High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev 17: 189-201, 2006.
22. Huttunen HJ and Rauvala H: Amphoterin as an extracellular regulator of cell motility: from discovery to disease. J Intern Med 255: 351-366, 2004.
23. Scaffidi P, Misteli T and Bianchi M: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195, 2002.
24. Salmivirta M, Rauvala H, Elenius K and Jalkanen M: Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp Cell Res 200: 444-451, 1992.
25. Parkkinen J and Rauvala H: Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J Biol Chem 266: 16730-16735, 1991.
26. Hori O, Brett J, Slattery T, et al: The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 270: 25752-25761, 1995.
27. Neeper M, Schmidt A, Brett J, et al: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267: 14998-15004, 1992.
28. Alescio T and Cassini A: Induction in vitro of tracheal buds by pulmonary mesenchyme grafted on tracheal epithelium. J Exp Zool 150: 83-94, 1962.
29. Demayo F, Minoo P, Plopper CG, Schuger L, Shannon J and Torday JS: Mesenchymal-epithelial interactions in lung development and repair: are modeling and remodeling the same process? Am J Physiol Lung Cell Mol Physiol 283: L510-L517, 2002.
30. Garantziotis S, Steele MP and Schwartz DA: Pulmonary fibrosis: thinking outside of the lung. J Clin Invest 114: 319-321, 2004.
31. Selman M and Pardo A: Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res 3: 3, 2002.
32. Knight D: Epithelium-fibroblast interactions in response to airway inflammation. Immunol Cell Biol 79: 160-164, 2001.
33. Wernert N: The multiple roles of tumour stroma. Virchows Arch 430: 433-443, 1997.
34. Bartling B, Demling N, Silber RE and Simm A: Proliferative stimulus of lung fibroblasts on lung cancer cells is impaired by RAGE. Am J Respir Cell Mol Biol 34: 83-91, 2006.
35. Micke P and Ostman A: Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 45 (suppl 2): 163-175, 2004.
36. Bartling B, Rehbein G, Silber RE and Simm A: Senescent fibroblasts induce moderate stress in lung epithelial cells in vitro. Exp Gerontol 41: 532-539, 2006.
37. Wood LJ, Mukherjee M, Dolde CE, et al: HMG-I/Y, a new c-Myc target gene and potential oncogene. Mol Cell Biol 20: 5490-5502, 2000.
38. Yoon S, Lee JY, Yoon BK, Bae DS and Choi DS: Effects of HMGB-1 overexpression on cell-cycle progression in MCF-7 cells. J Korean Med Sci 19: 321-326, 2004.
39. The cancer genome anatomic project. cgap.nci.nih.gov/SAGE/AnatomicViewer.
40. Cohen-Jonathan E, Toulas C, Monteil S, et al: Radioresistance induced by the high molecular forms of the basic fibroblast growth factor is associated with an increased G2 delay and a hyperphosphorylation of p34CDC2 in HeLa cells. Cancer Res 57: 1364-1370, 1997.
41. Konig A, Menzel T, Lynen S, et al: Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis. Leukemia 11: 258-265, 1997.
42. Miyake H, Hara I, Gohji K, Yoshimura K, Arakawa S and Kamidono S: Expression of basic fibroblast growth factor is associated with resistance to cisplatin in a human bladder cancer cell line. Cancer Lett 123: 121-126, 1998.
43. Muerkoster S, Wegehenkel K, Arlt A, et al: Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res 64: 1331-1337, 2004.
44. Muller S, Ronfani L and Bianchi ME: Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J Intern Med 255: 332-343, 2004.
45. Falciola L, Spada F, Calogero S, et al: High mobility group 1 protein is not stably associated with the chromosomes of somatic cells. J Cell Biol 137: 19-26, 1997.
46. Wen L, Huang JK, Johnson BH and Reeck GR: A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. Nucleic Acids Res 17: 1197-1214, 1989.
47. Bonaldi T, Talamo F, Scaffidi P, et al: Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22: 5551-5560, 2003.
48. Youn JH and Shin JS: Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 177: 7889-7897, 2006.
49. Ramachandran C, Yau P, Bradbury EM, Shyamala G, Yasuda H and Walsh DA: Phosphorylation of high-mobility-group proteins by the calcium-phospholipid- dependent protein kinase and the cyclic AMP-dependent protein kinase. J Biol Chem 259: 13495-13503, 1984.
50. Sakamoto R, Okano M, Takena H and Ohtsuki K: Inhibitory effect of glycyrrhizin on the phosphorylation and DNA-binding abilities of high mobility group proteins 1 and 2 in vitro. Biol Pharm Bull 24: 906-911, 2001.
51. Pallier C, Scaffidi P, Chopineau-Proust S, et al: Association of chromatin protein high mobility group box (HMGB) 1 and HMGB2 with mitotic chromosomes. Mol Biol Cell 14: 3414-3426, 2003.
52. Yoshizaki T, Sato H and Furukawa M: Recent advances in the regulation of matrix metalloproteinase 2 activation: From basic research to clinical implication. Oncol Rep 9: 607-611, 2002.